News and Stories About immunotherapy

A sports quote became the rallying cry for an Ohio teacher and coach fighting pancreatic cancer.

“Life is basically back to normal.” These are the words of five-year stage IV pancreatic cancer survivor, Lynne Holcomb, of […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today’s article describes the complex and changing landscape of clinical […]
READ MORE

Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

After losing her mom and uncle to pancreatic cancer, Nancy made an impact by donating to PanCAN to fund Ingunn’s early-career research […]

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: We recently announced the recipients of the Pancreatic Cancer Action Network’s (PanCAN) 2020 research grants. Now we’d like […]
READ MORE

Editor’s note: “Jeopardy!” host Alex Trebek and former Sen. Harry Reid have publicly mentioned being treated with an experimental immunotherapy […]
READ MORE

A drug that received unprecedented approval in the U.S. three years ago is now available for even more patients. In […]
READ MORE

Editor’s note: May is National Cancer Research Month, which provides an opportunity to highlight the incredible scientific and clinical research […]
READ MORE

All the way across the country from one another, two pancreatic cancer researchers made similar discoveries in their labs. Rushika […]
READ MORE

About one in four pancreatic cancer patients have changes in their tumor that suggest certain treatments may work particularly well […]
READ MORE

A recent paper published in the prestigious journal Lancet Oncology showed that the Pancreatic Cancer Action Network’s (PanCAN) Know Your […]
READ MORE

Stage IV pancreatic cancer survivor Ken Harding was no longer having great results after nine months on standard chemotherapy.  But […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

When immunology expert Ingunn Stromnes, PhD, assistant professor of microbiology and immunology at the University of Minnesota, unexpectedly discovered a […]
READ MORE

A new study out today in Cell links tumor bacteria to long-term pancreatic cancer survival. Examining tumor samples from pancreatic […]
READ MORE

Cancer immunotherapy involves empowering the patient’s immune system to recognize, attack and destroy cancer cells. While remarkable results have been […]
READ MORE

“I’ve been attending the American Association for Cancer Research (AACR) annual meetings for several years, and this year’s conference was […]
READ MORE

The 2018 Nobel Prize in Physiology or Medicine has been awarded to James (Jim) Allison, PhD, and Tasuku Honjo, MD, […]
READ MORE

When doctors told David Watson of Santa Monica, Calif., that he had type 2 diabetes in November 2016, he couldn’t […]
READ MORE

This year, the Pancreatic Cancer Action Network (PanCAN) awarded eight prestigious research grants to scientists and clinicians in the United […]
READ MORE

Cancer immunotherapy involves efforts to harness the patient’s own immune system to recognize and attack tumor cells. To date, the […]
READ MORE

Pancreatic Cancer Action Network (PanCAN) grantee Dung Le, MD, provided commentary in the April 2018 issue of Smithsonian Magazine. The […]
READ MORE

Scientists have known for quite some time that pancreatic tumors are surrounded by an especially dense and complex “stroma,” a […]
READ MORE

Editor’s note: This article is another installment in our “Year in Review” series recapping the year’s top stories in pancreatic […]
READ MORE

A multi-institutional research team, including Vinod Balachandran, MD, and Steven Leach, MD, set out to ask an important question: “What […]
READ MORE

The second episode of the three-part Discovery documentary on clinical trials, First in Human, follows the gripping story of three […]
READ MORE

A Pancreatic Cancer Action Network Career Development Award in 2014 allowed David DeNardo, PhD, to ask and answer important questions […]
READ MORE

Last week, we shared the exciting news that an immunotherapy agent, Keytruda, was the first drug approved by the FDA […]
READ MORE

For the first time, the U.S. Food and Drug Administration (FDA) has approved a cancer drug based only on molecular […]
READ MORE

Thanks to the generosity of donors, we awarded our largest-ever grant of $2 million in 2016 to accelerate a large-scale […]
READ MORE

The more researchers analyze the interaction between pancreatic cancer cells and the patient’s immune system, the more complex the relationship […]
READ MORE

Together, we have been relentless in fighting for increased funding for pancreatic cancer research and today, we are proud to […]
READ MORE

Pancreatic cancer recently moved from the fourth to the third leading cause of cancer-related death in the United States, and […]
READ MORE

Preliminary results from an early-phase immunotherapy clinical trial suggest that an innovative treatment could be effective for patients with locally-advanced or borderline-resectable pancreatic cancer.